Lidocaine Hydrochloride Solution
NDC Package 0116-4027-40
Package Information
Lidocaine Hydrochloride solution is lidocaine Hydrochloride Oral Topical Solution, USP 2% is indicated for the production of topical anesthesia of irritated or inflamed mucous membranes of the mouth and pharynx. This formulation utilizes a solution delivery system. Marketed by Xttrium Laboratories, Inc., this product is identified by NDC 0116-4027 and is authorized under FDA application ANDA087872.
Identification & Billing
- RxCUI: 1010739 - lidocaine HCl 2 % Mucous Membrane Topical Solution
- RxCUI: 1010739 - lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution
- RxCUI: 1010739 - lidocaine HCl 2 % Oral Topical Solution
- RxCUI: 1010739 - lidocaine HCl 2 % Oromucosal Solution
Clinical Specifications
- Oral - Administration to or by way of the mouth.
- Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Regulatory & Marketing
Hierarchy Structure
- 0116 - Xttrium Laboratories, Inc.
- 0116-4027 - Lidocaine Hydrochloride
- 0116-4027-40 - 4 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 15 mL in 1 CUP, UNIT-DOSE (0116-4027-15)
- 0116-4027 - Lidocaine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0116-4027). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0116-4027-40 identifies a specific commercial package of 4 tray in 1 case / 10 cup, unit-dose in 1 tray / 15 ml in 1 cup, unit-dose (0116-4027-15) of Lidocaine Hydrochloride, a human prescription drug labeled by Xttrium Laboratories, Inc.. This solution is formulated for oral; topical use and contains lidocaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Xttrium Laboratories, Inc. on March 28, 2023. The current certification is valid through December 31, 2027.
How is this Xttrium Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00116402740. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.